Sandu Pharmaceuticals Ltd — Important, 07-04-2026: Company Update

Sandu Pharmaceuticals has confirmed the diligent processing of its share dematerialisation activities for the quarter ended March 31. The company's Registrar and Share Transfer Agents verified that all physical shares submitted for conversion to electronic form were confirmed to depositories, and their corresponding certificates were properly mutilated and cancelled. This ensures that depositories are accurately registered as owners in the company's records within the required timelines, maintaining the integrity of electronic share transactions and providing clarity for investors regarding their holdings.